Subgroups | Number of studies | Participants (n) | Heterogeneity test outcomes | Effects model | Meta-analysis | Interaction p-value | |
---|---|---|---|---|---|---|---|
(Experimental/Control) | p-value | I2 (%) | RR (95% CI) | ||||
Intervention | Â | Â | Â | Â | Â | Â | 0.51 |
 LBBF | 368/368 | 0.000 | 96.9% | Random | 0.23 (0.06, 0.94) |  | |
 LBBF +SSC | 172/168 | 0.096 | 57.3% | Random | 0.39 (0.21, 0.71) |  | |
Deliver mode | Â | Â | Â | Â | Â | Â | 0.97 |
 Vaginal delivery | 1 [45] | 48/48 | – | – | Random | 0.27 (0.15, 0.51) |  |
 Vaginal delivery & caesarean | 492/488 | 0.000 | 94.9% | Random | 0.28 (0.12, 0.66) |  | |
Maternal category | Â | Â | Â | Â | Â | Â | 0.14 |
 Primipara | 1 [44] | 74/70 | – | – | Random | 0.57 (0.39, 0.84) |  |
 Primipara & multipara | 466/466 | 0.000 | 95.6% | Random | 0.24 (0.08, 0.70) |  |